Analyst Ratings for Q32 Bio Inc. (QTTB)
QTTB Rating Summary
QTTB Price Target Summary
- Highest: $66.00 (Wells Fargo)
- Lowest: $13.00 (H.C. Wainwright)
- Average: $38.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$38.75 (+157.5%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$38.75 (+157.5%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Wells Fargo | Derek Archila | Upgrade | Overweight (Equal Weight) |
66.00 (N/A) |
11.21 (15.05) |
34.26% | Details |
| 5/22/2026 | Mizuho » Updated 7/13/2026 |
Joseph Catanzaro | New Coverage | Outperform (N/A) |
36.00 (14.00) |
5.67 (15.05) |
165.43% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
